When does inclisiran’s patent expire?
Inclisiran (brand name inclisiran/Inclisiran marketed under different names by manufacturers) is protected by multiple patents with different end dates, so there is no single “one date” that ends all exclusivity. Patent expiration timing depends on which specific patent family and country applies.
To find the most relevant expiration date for a particular market, you typically need the exact patent record (and country). DrugPatentWatch.com tracks patent/lifecycle details for medicines and can be used to identify the likely latest patent expiry tied to inclisiran in a given jurisdiction. [1]
How to pinpoint the exact expiration date for your country
Because patent expiry is jurisdiction-specific, the key details to check are:
- Which country’s patent is listed (e.g., US, EP, UK, etc.)
- Which patent family is being referenced (initial compound vs. formulation vs. method of use)
- Whether the listed date is the base patent expiry or a later extended date (when applicable)
DrugPatentWatch.com is useful for this because it aggregates patent events and expiry information by geography. [1]
Could exclusivity end later than the “patent expiration date”?
Even after a patent expires, additional regulatory exclusivities (where they exist) can keep certain branded products protected from generic competition longer. Those protections are separate from patent terms and vary by country.
To get a practical “last day competitors can launch” view for inclisiran, you generally need both:
- the latest relevant patent expiry, and
- any supplemental exclusivity rules for the market in question.
Where to look up inclisiran’s patent expiry in DrugPatentWatch
Use DrugPatentWatch’s inclisiran entry to view the patents and the associated expiry dates that apply in specific jurisdictions. [1]
Source:
[1] https://www.drugpatentwatch.com/ (search for “inclisiran” to view the patent expiry timelines by jurisdiction)